Trial Profile
A Special Access Program for the Prophylactic Vaccination With IMVAMUNE® for Personnel Working Directly With or in the Vicinity of Replicating Vaccinia Virus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2020
Price :
$35
*
At a glance
- Drugs Smallpox vaccine (Primary)
- Indications Monkeypox; Smallpox
- Focus Therapeutic Use
- Sponsors Bavarian Nordic
- 22 Mar 2018 New trial record